1.PCR-based detection of genes encoding virulence determinants in Staphylococcus aureus from bovine subclinical mastitis cases.
Dewanand Rajaram KALOREY ; Yuvaraj SHANMUGAM ; Nitin Vasantrao KURKURE ; Kapil Kamalakarrao CHOUSALKAR ; Sukhadeo Baliram BARBUDDHE
Journal of Veterinary Science 2007;8(2):151-154
The present study was carried out to genotypically characterize Staphylococcus aureus (S. aureus) isolated from bovine mastitis cases. A total of 37 strains of S. aureus were isolated during processing of 552 milk samples from 140 cows. The S. aureus strains were characterized phenotypically, and were further characterized genotypically by polymerase chain reaction using oligonucleotide primers that amplified genes encoding coagulase (coa), clumping factor (clfA), thermonuclease (nuc), enterotoxin A (entA), and the gene segments encoding the immunoglobulin G binding region and the X region of protein A gene spa. All of the isolates yielded an amplicon with a size of approximately 1,042 bp of the clfA gene. The amplification of the polymorphic spa gene segment encoding the immunoglobulin G binding region was observed in 34 isolates and X-region binding was detected in 26 isolates. Amplification of the coa gene yielded three different products in 20, 10, and 7 isolates. The amplification of the thermonuclease gene, nuc, was observed in 36 out of 37 isolates. All of the samples were negative for the entA gene. The phenotypic and genotypic findings of the present strategies might provide an understanding of the distribution of the prevalent S. aureus clones among bovine mastitis isolates, and might aid in the development of steps to control S. aureus infections in dairy herds.
Animals
;
Bacterial Proteins/chemistry/genetics
;
Cattle
;
Coagulase/chemistry/genetics
;
DNA, Bacterial/chemistry/genetics
;
Endonucleases/chemistry/genetics
;
Female
;
Mastitis, Bovine/*microbiology
;
Micrococcal Nuclease/chemistry/genetics
;
Milk/microbiology
;
Polymerase Chain Reaction/veterinary
;
Staphylococcal Infections/microbiology/*veterinary
;
Staphylococcus aureus/*genetics/pathogenicity
;
Virulence Factors/chemistry/*genetics
2.Study of UV DNA Repair Endonucleases with Respect to Skin Cancers.
Joon KIM ; Yong Suk NAM ; Young In PARK
Journal of the Korean Cancer Association 1997;29(4):599-607
No abstract available
DNA Repair*
;
DNA*
;
Endonucleases*
;
Skin Neoplasms*
;
Skin*
;
Xeroderma Pigmentosum
3.Application and optimization of CRISPR/Cas system in bacteria.
Junhao FU ; Fayu YANG ; Haihua XIE ; Feng GU
Chinese Journal of Biotechnology 2019;35(3):341-350
Clustered regular interspaced short palindromic repeats (CRISPR) system has been widely used in recent years. Compared with traditional genome editing technology, CRISPR/Cas system has notable advantages, including high editing efficiency, high specificity, low cost and the convenience for manipulation. Type Ⅱ and Ⅴ CRISPR/Cas system only requires a single Cas9 protein or a single Cpf1 protein as effector nucleases for cutting double-stranded DNA, developed as genome editing tools. At present, CRISPR/Cas9 technology has been successfully applied to the genome editing of eukaryotes such as zebrafish, mice and human cells, whereas limited progress has been made in the genome editing of bacteria. In our review, we describe CRISPR/Cas system, its mechanism and summarize the optimization and progress of genome editing in bacteria.
Animals
;
Bacteria
;
CRISPR-Cas Systems
;
Endonucleases
;
Gene Editing
;
Humans
;
Mice
4.Regulatory framework of genome-edited products - a review.
Yuanyuan YAN ; Jinjie ZHU ; Chuanxiao XIE ; Changlin LIU
Chinese Journal of Biotechnology 2019;35(6):921-930
Genome editing is a genetic engineering technique that uses site-directed cleavage activity of specific artificial nucleases and endogenous DNA damage repair activity to generate insertions, deletions or substitutions in the targeted genomic loci. As the accuracy and efficiency of genome editing is improving and the operation is simple, the application of genome editing is expanding. This article provides an overview of the three major genome editing technologies and genome editing types, and the regulatory frameworks for genome-edited products were summarized in the United States, the European Union, and other countries. At the same time, based on the Chinese safety management principles and systems for genetically modified organisms (GMOs), the authors proposed a regulatory framework for genome-edited products. Genome-edited products should first be classified according to whether containing exogenous genetic components such as Cas9 editing enzymes or not. They should be regulated as traditional genetically modified organisms if they do. Otherwise, the regulation of genome-edited products depends on targeted modifications.
CRISPR-Cas Systems
;
Endonucleases
;
Gene Editing
;
Genome
;
Mutagenesis, Site-Directed
5.Advances of CRISPR/dCas9 system in live cell imaging.
Siyu LIN ; Xing ZHONG ; Lixin MA ; Jie QIAO ; Yi LIU
Chinese Journal of Biotechnology 2021;37(9):3061-3070
The study of distinct genes, chromosomes and the spatio-temporal relationships between them is of great significance in genetics, developmental biology and biomedicine. CRISPR/Cas9 has become the most widely used gene editing tool due to its excellent targeting ability. Recently, researchers have developed a series of advanced live cell imaging techniques based on the nuclease-inactivated mutant of Cas9 (dCas9), providing rapid and convenient tools for high-resolution imaging of specific sites in the chromatin and genome. This review summarizes the advances of CRISPR/dCas9 system in live cell imaging from three aspects, including the strategies of cell delivery, optimization of the fluorescence signals, as well as orthogonal and multicolor imaging. Furthermore, we shed light on the development trends and prospects of this field.
CRISPR-Cas Systems/genetics*
;
Chromatin
;
Endonucleases
;
Gene Editing
6.Human FEN-1 can process the 5'-flap DNA of CTG/CAG triplet repeat derived from human genetic diseases by length and sequence dependent manner.
Experimental & Molecular Medicine 2002;34(4):313-317
Trinucleotide repeat (TNR) instability can cause a variety of human genetic diseases including myotonic dystrophy and Huntington's disease. Recent genetic data show that instability of the CAG/CTG repeat DNA is dependent on its length and replication origin. In yeast, the RAD27 (human FEN-1 homologue) null mutant has a high expansion frequency at the TNR loci. We demonstrate here that FEN-1 processes the 5'-flap DNA of CTG/CAG repeats, which is dependent on the length in vitro. FEN-1 protein can cleave the 5'-flap DNA containing triplet repeating sequence up to 21 repeats, but the activity decreases with increasing size of flap above 11 repeats. In addition, FEN-1 processing of 5'-flap DNA depends on sequence, which play a role in the replication origin-dependent TNR instability. Interestingly, FEN-1 can cleave the 5'-flap DNA of CTG repeats better than CAG repeats possibly through the flap-structure. Our biochemical data of FEN-1's activity with triplet repeat DNA clearly shows length dependence, and aids our understanding on the mechanism of TNR instability.
Base Sequence
;
DNA, Single-Stranded/*metabolism
;
Endodeoxyribonucleases/genetics/*metabolism
;
Flap Endonucleases
;
Gene Expression Regulation
;
Genetic Diseases, Inborn/*genetics
;
Human
;
Nucleic Acid Conformation
;
Trinucleotide Repeat Expansion
;
*Trinucleotide Repeats
7.Human FEN-1 can process the 5'-flap DNA of CTG/CAG triplet repeat derived from human genetic diseases by length and sequence dependent manner.
Experimental & Molecular Medicine 2002;34(4):313-317
Trinucleotide repeat (TNR) instability can cause a variety of human genetic diseases including myotonic dystrophy and Huntington's disease. Recent genetic data show that instability of the CAG/CTG repeat DNA is dependent on its length and replication origin. In yeast, the RAD27 (human FEN-1 homologue) null mutant has a high expansion frequency at the TNR loci. We demonstrate here that FEN-1 processes the 5'-flap DNA of CTG/CAG repeats, which is dependent on the length in vitro. FEN-1 protein can cleave the 5'-flap DNA containing triplet repeating sequence up to 21 repeats, but the activity decreases with increasing size of flap above 11 repeats. In addition, FEN-1 processing of 5'-flap DNA depends on sequence, which play a role in the replication origin-dependent TNR instability. Interestingly, FEN-1 can cleave the 5'-flap DNA of CTG repeats better than CAG repeats possibly through the flap-structure. Our biochemical data of FEN-1's activity with triplet repeat DNA clearly shows length dependence, and aids our understanding on the mechanism of TNR instability.
Base Sequence
;
DNA, Single-Stranded/*metabolism
;
Endodeoxyribonucleases/genetics/*metabolism
;
Flap Endonucleases
;
Gene Expression Regulation
;
Genetic Diseases, Inborn/*genetics
;
Human
;
Nucleic Acid Conformation
;
Trinucleotide Repeat Expansion
;
*Trinucleotide Repeats
8.Progress in gene editing technologies for Saccharomyces cerevisiae.
Hongbiao LI ; Xiaolin LIANG ; Jingwen ZHOU
Chinese Journal of Biotechnology 2021;37(3):950-965
Saccharomyces cerevisiae is one of the most important hosts in metabolic engineering. Advanced gene editing technology has been widely used in the design and construction of S. cerevisiae cell factories. With the rapid development of gene editing technology, early gene editing technologies based on recombinase and homologous recombination have been gradually replaced by new editing systems. In this review, the principle and application of gene editing technology in S. cerevisiae are summarized. Here, we first briefly describe the classical gene editing techniques of S. cerevisiae. Then elaborate the genome editing system of MegNs, ZFNs and TALENs based on endonuclease. The latest research progress is especially introduced and discussed, including the CRISPR/Cas system, multi-copy integration of heterologous metabolic pathways, and genome-scale gene editing. Finally, we envisage the application prospects and development directions of Saccharomyces cerevisiae gene editing technology.
CRISPR-Cas Systems/genetics*
;
Endonucleases/genetics*
;
Gene Editing
;
Saccharomyces cerevisiae/genetics*
;
Technology
9.Development and challenges of gene editing technology.
Yao LIU ; Yingzhe XIONG ; Zhenze CAI ; Bing ZHANG
Chinese Journal of Biotechnology 2019;35(8):1401-1410
Gene editing is a technique for modifying gene fragments. The novel gene editing technology focuses on the field of artificial nuclease cleavage technology, mainly ZFN technology, TALEN technology, CRISPR technology and base editing technology. The continuous improvement of gene editing technology has promoted the rapid development of agriculture, animal husbandry and biomedicine, but at the same time, technical defects and ethical controversy have brought enormous challenges to its own development. This article will briefly discuss the development and challenges of gene editing technology, as well as the views at home and abroad, and hope to inspire readers to recognize gene editing technology.
Agriculture
;
Animals
;
Clustered Regularly Interspaced Short Palindromic Repeats
;
Endonucleases
;
Gene Editing
10.Development of a CRISPR/Cpf1 gene editing system in silkworm Bombyx mori.
Zhanqi DONG ; Qi QIN ; Xinling ZHANG ; Kejie LI ; Peng CHEN ; Minhui PAN
Chinese Journal of Biotechnology 2021;37(12):4342-4350
The CRISPR/Cas9 gene editing system has been widely used in basic research, gene therapy and genetic engineering due to its high efficiency, fast speed and convenience. Meanwhile, the discovery of novel CRISPR/Cas systems in the microbial community also accelerated the emergence of novel gene editing tools. CRISPR/Cpf1 is the second type (V type) CRISPR system that can edit mammalian genome. Compared with the CRISPR/Cas9, CRISPR/Cpf1 can use 5'T-PAM rich region to increase the genome coverage, and has many advantages, such as sticky end of cleavage site and less homologous recombination repair. Here we constructed three CRISPR/Cpf1 (AsCpf1, FnCpf1 and LbCpf1) expression vectors in silkworm cells. We selected a highly conserved BmHSP60 gene and an ATPase family BmATAD3A gene to design the target gRNA, and constructed gHSP60-266 and gATAD3A-346 knockout vectors. The efficiency for editing the target genes BmATAD3A and BmHSP60 by AsCpf1, FnCpf1 and LbCpf1 were analyzed by T7E1 analysis and T-clone sequencing. Moreover, the effects of target gene knockout by different gene editing systems on the protein translation of BmHSP60 and BmATAD3A were analyzed by Western blotting. We demonstrate the CRISPR/Cpf1 gene editing system developed in this study could effectively edit the silkworm genome, thus providing a novel method for silkworm gene function research, genetic engineering and genetic breeding.
Animals
;
Bombyx/metabolism*
;
CRISPR-Cas Systems/genetics*
;
Endonucleases/genetics*
;
Gene Editing
;
RNA, Guide/genetics*